Viridian Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRDN and other ETFs, options, and stocks.

About VRDN

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. 

CEO
Jonathan Violin
CEOJonathan Violin
Employees
50
Employees50
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2006
Founded2006
Employees
50
Employees50

VRDN Key Statistics

Market cap
791.90M
Market cap791.90M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
385.74K
Average volume385.74K
High today
$21.00
High today$21.00
Low today
$20.23
Low today$20.23
Open price
$20.98
Open price$20.98
Volume
268.65K
Volume268.65K
52 Week high
$26.22
52 Week high$26.22
52 Week low
$9.47
52 Week low$9.47

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

VRDN Earnings

-$2.91
-$1.94
-$0.97
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.